Atomoxetine use while Breastfeeding

Drugs containing Atomoxetine: Strattera

Atomoxetine Levels and Effects while Breastfeeding

Summary of Use during Lactation

There is no published experience with atomoxetine during breastfeeding, although reports from the manufacturer found no serious advese effects in two breastfed infants. An alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Possible Effects on Lactation

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Amphetamine, Methylphenidate

References

1. Besag FM. ADHD treatment and pregnancy. Drug Saf. 2014;37:397-40. PMID: 24794209

Atomoxetine Identification

Substance Name

Atomoxetine

CAS Registry Number

83015-26-3

Drug Class

  • Adrenergic Uptake Inhibitors

Administrative Information

LactMed Record Number

826

Information from the National Library of Medicine's LactMed Database.

Last Revision Date

2014-07-08

Disclaimer

Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

See Also...

Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.

Hide
(web1)